 

Active ingredient: Acetaminophen; Oxycodone Hydrochloride 

 

Form/Route: Tablets/Oral 

 

Recommended studies: 

 

Acetaminophen; Oxycodone Hydrochloride Tablets are a DESI1 effective drug for which there 
are no known or suspected bioequivalence problems, and as such is rated “AA” in the 
FDA/CDER’s Approved Drug Products with Therapeutic Equivalence Evaluations (“Orange 
Book”). 

______________________________________________________________________________ 

 

Analytes to measure (in appropriate biological fluid): Not Applicable 

 

Bioequivalence based on (90% CI): Not Applicable 

 

Waiver request of in-vivo testing: 325 mg/2.5 mg, 325 mg/5 mg, 325 mg/7.5 mg, 325 mg/10 
mg, 500 mg/2.5 mg, 500 mg/7.5 mg, and 650 mg/10 mg pursuant to 21 CFR 320.22 (c) provided 
that the in-vitro dissolution profiles of the proposed product are comparable to those of the 
reference product. 

 

Dissolution test method and sampling times: 

 

Please note that a Dissolution Methods Database is available to the public at the OGD website at 
http://www.accessdata.fda.gov/scripts/cder/dissolution/. Please find the dissolution information 
for this product at this website. Please conduct comparative dissolution testing on 12 dosage 
units each of all strengths of the test and reference products. Specifications will be determined 
upon review of the application. 

 

 

 

1 Drug Efficacy Study Implementation 


